What does this research mean for the field?

Transdermal buprenorphine is an effective analgesic for up to 48 hours in guinea pigs, maintaining therapeutic plasma levels with minimal side effects. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

This study assessed how well transdermal buprenorphine works and how the body processes it in guinea pigs.

February 19, 2026Journal of the American Association for Laboratory Animal Science

Pharmacokinetics and Paw Withdraw Pressure in Guinea Pigs (Cavia porcellus) Treated with Transdermal Buprenorphine

View Full Paper

Ask AI

Bookmark

Authors

SKShawn Kozlov SGSelena M. Guerrero-Martin GPGrace Payne

Discussion

Member takes

Overview

Findings demonstrate effective analgesia from transdermal buprenorphine in guinea pigs, suggesting improved pain management methods.

Key Points

This study assessed how well transdermal buprenorphine works and how the body processes it in guinea pigs.
Administered transdermal buprenorphine at a dose of 2.7 mg per guinea pig.
Measured plasma concentration and paw withdraw pressure (PWP) at various time points after administration.
Monitored sedation scores and body temperature over time.
Plasma levels peaked at 77.8 ng/mL at 1 hour, remaining therapeutic for 120 hours.
PWP peaked at 671.2 g at 24 hours, showing effective pain relief for up to 48 hours.
Minimal side effects were observed, with normal body temperatures and weight.

Cite This Study

Kozlov et al. (2026) studied this question.

synapsesocial.com/papers/6996a768ecb39a600b3ed016 https://doi.org/10.30802/aalas-jaalas-25-161

View Full Paper

Ask AI

Bookmark

February 19, 2026Journal of the American Association for Laboratory Animal Science

Pharmacokinetics and Paw Withdraw Pressure in Guinea Pigs (Cavia porcellus) Treated with Transdermal Buprenorphine

View Full Paper

Ask AI

Bookmark

Authors

SKShawn Kozlov SGSelena M. Guerrero-Martin GPGrace Payne

Discussion

Member takes

Overview

Findings demonstrate effective analgesia from transdermal buprenorphine in guinea pigs, suggesting improved pain management methods.

Key Points

This study assessed how well transdermal buprenorphine works and how the body processes it in guinea pigs.
Administered transdermal buprenorphine at a dose of 2.7 mg per guinea pig.
Measured plasma concentration and paw withdraw pressure (PWP) at various time points after administration.
Monitored sedation scores and body temperature over time.
Plasma levels peaked at 77.8 ng/mL at 1 hour, remaining therapeutic for 120 hours.
PWP peaked at 671.2 g at 24 hours, showing effective pain relief for up to 48 hours.
Minimal side effects were observed, with normal body temperatures and weight.

Cite This Study

Kozlov et al. (2026) studied this question.

synapsesocial.com/papers/6996a768ecb39a600b3ed016 https://doi.org/10.30802/aalas-jaalas-25-161

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark